£83.88

Springer Therapeutic Applications of Dopamine D3 Receptor Function: New Insight After 30 Years Of Research: 60 (Current Topics in Behavioral Neurosciences, 60)

Price data last checked 11 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£84 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 80 days · 80 data points (no recent data)

Historical
Generating forecast…
£95.26 £82.74 £85.47 £88.20 £90.94 £93.67 £96.40 25 April 2026 14 May 2026 03 June 2026 23 June 2026 13 July 2026

Price Distribution

Price distribution over 80 days • 6 price levels

Days at Price
Current Price
7 days · current 14 days 12 days 21 days 7 days 19 days 0 5 11 16 21 £84 £85 £87 £89 £92 £95 Days at Price

Price Analysis

Most common price: £89 (21 days, 26.3%)

Price range: £84 - £95

Price levels: 6 different prices over 80 days

Description

The CTBN volume Therapeutic Applications of Dopamine D3 Receptor Function reviews the state of the knowledge on the dopamine D3 receptor and its role in human behavior and disease (i.e.: neuropsychiatric illnesses including schizophrenia, mood disorders, Parkinson’s disease, restless legs syndrome, addictions and substance use disorders). The volume is written by leading experts across multidisciplinary areas (imaging, biobehavioral testing and clinical trials, preclinical models / molecular pharmacology) converging on the therapeutic implications / potential of the D3 receptor. The D3 dopamine receptor is a member of the D2-like family of G protein-coupled receptors. It was cloned and characterized almost 25 years ago. A key feature of the D3 dopamine receptor system, which has attracted considerable attention, is its anatomical localization remarkably restricted to the limbic circuitry. This has spurred the hypothesis that D3 involvement could contribute to the pathophysiology of neuropsychiatric disorders (or to some features of neuropsychiatric disorders), including but not limited to psychosis, addictions and substance abuse, mood and movement disorders.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
03 January 2023
Listed Since
08 November 2022

Barcode

No barcode data available

Similar Products You Might Like

Dopamine Receptor Technologies: 96 (Neuromethods, 96)
97% match

Dopamine Receptor Technologies: 96 (Neuromethods, 96)

Humana

£79.91 14 Jul 2026
Dopamine (Volume 211) (Progress in Brain Research, Volume 211)
97% match

Dopamine (Volume 211) (Progress in Brain Research, Volume 211)

Elsevier

£175.00 19 Jun 2026
Das dopaminerge Verstärkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate: 100 (Monographien aus dem Gesamtgebiete der Psychiatrie, 100)
97% match

Das dopaminerge Verstärkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate: 100 (Monographien aus dem Gesamtgebiete der Psychiatrie, 100)

Springer

£69.26 06 Jul 2026
Das dopaminerge Verstärkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate: 100 (Monographien aus dem Gesamtgebiete der Psychiatrie, 100)
97% match

Das dopaminerge Verstärkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate: 100 (Monographien aus dem Gesamtgebiete der Psychiatrie, 100)

Springer

£54.69 06 Jul 2026
Dopamine in the CNS: Pt. 1 (Handbook of Experimental Pharmacology)
97% match

Dopamine in the CNS: Pt. 1 (Handbook of Experimental Pharmacology)

Springer

£82.56 11 Jul 2026
Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance (Progress in Brain Research): 172
97% match

Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance (Progress in Brain Research): 172

Elsevier

£182.59 10 Jul 2026
5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)
96% match

5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)

Humana

£141.73 10 Jul 2026
Dopamine (Volume 21) (Handbook of Chemical Neuroanatomy, Volume 21)
96% match

Dopamine (Volume 21) (Handbook of Chemical Neuroanatomy, Volume 21)

Elsevier

£280.00 19 Jun 2026
Dopamine - Glutamate Interactions in the Basal Ganglia: 49 (Frontiers in Neuroscience)
96% match

Dopamine - Glutamate Interactions in the Basal Ganglia: 49 (Frontiers in Neuroscience)

CRC Press

£120.23 08 Jul 2026
New Developments in Dopamine Research
96% match

New Developments in Dopamine Research

£104.99 03 Jul 2026
Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)
96% match

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Humana

£80.64 07 Jul 2026
Handbook of Basal Ganglia Structure and Function (Volume 24) (Handbook of Behavioral Neuroscience, Volume 24)
96% match

Handbook of Basal Ganglia Structure and Function (Volume 24) (Handbook of Behavioral Neuroscience, Volume 24)

Academic Press

£115.00 02 Jul 2026
Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)
96% match

Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)

Academic Press

£111.79 14 Jul 2026
Neurobiology of DOPA as a Neurotransmitter
96% match

Neurobiology of DOPA as a Neurotransmitter

CRC Press

£199.00 23 Jun 2026
Neuropsychopharmacology: 64 (Journal of Neural Transmission. Supplementa, 64)
96% match

Neuropsychopharmacology: 64 (Journal of Neural Transmission. Supplementa, 64)

Springer

£87.01 06 Jul 2026
Sage Brain and Behaviour - Neurotransmission Textbook
96% match

Sage Brain and Behaviour - Neurotransmission Textbook

Sage Publications

£136.00 15 Jul 2026
Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)
96% match

Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)

Springer

£77.33 13 Jul 2026
Brain Function and Psychotropic Drugs (Oxford Medical Publications)
96% match

Brain Function and Psychotropic Drugs (Oxford Medical Publications)

Oxford University Press

£59.00 01 Jul 2026
CRC Press Neurochemistry of Abused Drugs - Addiction Studies
96% match

CRC Press Neurochemistry of Abused Drugs - Addiction Studies

CRC Press

£136.81 15 Jul 2026
International Review of Neurobiology: Vol 54: Volume 54
96% match

International Review of Neurobiology: Vol 54: Volume 54

Academic Press

£46.64 29 Jun 2026
Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models
96% match

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Academic Press

£101.79 15 Jul 2026
Psychopharmacology: 13 (Neuromethods, 13)
96% match

Psychopharmacology: 13 (Neuromethods, 13)

Humana

£166.29 09 Jul 2026
Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)
96% match

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Springer

£128.31 23 Jun 2026